Loading provider…
Loading provider…
Internal Medicine Physician in Gillette, WY
NPI: 1093785735Primary Practice Location
CAMPBELL COUNTY HEALTH
501 S Burma Ave, Gillette, WY
Primary Employer
Health Concepts
rchealthconcepts.com
HQ Phone
Get MD Richard's Phone Numberphone_androidMobile
Get MD Richard's MobileLooking to connect with more Physicians?
Dmand AI gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Get Started for Freearrow_outwardSD State Medical License
| # | Procedure Code (CPT®/HCPCS II) | Procedure Patients | Procedure Volume |
|---|---|---|---|
| 1 | 36415Insertion of needle into vein for collection of blood sample | 194 | 387 |
| 2 | 99214Established patient office or other outpatient visit, 30-39 minutes | 159 | 293 |
| 3 | G0439Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 135 | 135 |
| 4 | 99213Established patient office or other outpatient visit, typically 15 minutes | 115 | 198 |
| 5 | G0008Administration of influenza virus vaccine | 79 | 79 |
Authors: Richard Davey, John Beigel, Horace Holley, Melanie Hoppers
Journal: Clin Infect Dis
Oseltamivir, amantadine, and ribavirin combination antiviral therapy versus oseltamivir monotherapy for the treatment of influenza: a multicentre, double-blind, randomised phase 2 trial.
Authors: Richard Davey, John Beigel, Horace Holley, Alex Slandzicki
Publication Date: 2017-05-22
Lead Sponsor: Helixmith Co., Ltd.
Intervention / Treatment: OTHER: Placebo, BIOLOGICAL: Engensis
Lead Sponsor: Helixmith Co., Ltd.
Intervention / Treatment: OTHER: Placebo, BIOLOGICAL: Engensis
Lead Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)
Intervention / Treatment: DRUG: Placebo, DRUG: Oseltamivir